Insmed (INSM) Misses Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mailGet Alerts INSM Hot Sheet
Price: $120.00 -3.21%
Revenue Growth %: +253.0%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +253.0%
Financial Fact:
Net loss attributable to common stockholders: -37.76M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Insmed (NASDAQ: INSM) reported Q1 EPS of ($1.42), $0.07 worse than the analyst estimate of ($1.35). Revenue for the quarter came in at $92.82 million versus the consensus estimate of $90.78 million.
For earnings history and earnings-related data on Insmed (INSM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
- Axion Minerals plans flow-through private placement of up to $440K
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
